Supply Chain News
ITM and Ariceum Sign Agreement to Supply Actinium-225 for Cancer Treatments
ITM Isotope Technologies Munich SE (ITM) has announced a supply agreement with Ariceum Therapeutics to deliver non-carrier-added (n.c.a.) Actinium-225 (Ac-225) for use in the development of Ariceum’s novel radiopharmaceutical therapies. The agreement is set to support Ariceum’s pipeline, which includes
14 January 2025